UC San Diego receives $8 million grant to study the genetics of substance use disorder

University of California San Diego School of Medicine has received a five-year, $8 million grant from the National Institute on Drug Abuse (NIDA) to study the genetics of substance use disorders.

Computer model helps tailor CML treatment to individual patients

Which medicine is best when you are affected by cancer? This can vary from person to person. A new method can help people with a

January 10, 2025

Aridis to delist from Nasdaq; Bicycle closes $200M+ offering

Aridis Pharmaceuticals is being taken off the Nasdaq, effective Wednesday. The biotech reported the news in an SEC filing Monday, saying that it will be

July 19, 2023

A faster, simpler, cheaper cancer cell therapy is about to be tested in humans

In a long-awaited study, patients in Australia will soon receive an IV infusion designed to transform their own immune cells into swarms of cancer-fighting drones.

July 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.